Dr Armand Sprecher: interview 2 and PDF transcript

Date:
23/02/2015
Reference:
OH3/2/2
Part of:
Ebola Voices Oral Histories
  • Born-digital archives
  • Online

Collection contents

Available online

View

In copyright

It is possible this item is protected by copyright and/or related rights. You may be able to use this digital item under a copyright exception, otherwise you need to obtain permission from the rights-holder(s). These may be identified elsewhere in the catalogue record. Read more about copyright.

Read further guidance on copyright exceptions in the UK.

Credit

Dr Armand Sprecher: interview 2 and PDF transcript. In copyright. Source: Wellcome Collection.

About this work

Description

[00:00:00] Armand Sprecher talks about use of experimental treatments for Ebola Patients, decision making around Dr Khan [Sheik Umar Khan] not being given ZMapp, comments on MSF being routinely accused of experimenting on Africans in Ebola outbreaks, controversy of Samaritan’s Purse workers receiving ZMapp, involvement of Public Health Agency of Canada in Sierra Leone. [00:04:45] Ethical issues and different arguments around administering medical trials/treatments/vaccine for Ebola. [00:09:50] MSF involvement in different vaccine trials. [00:12:00] ZMapp, RCT [Randomised controlled trial] of ZMapp, less cases of Ebola now, comments on things he hopes would be resolved for future Ebola outbreaks; treatments and ‘marketing’ problem. [00:16:00] Reflects on mobility of people being a main problem of this Ebola outbreak, lack of contact tracing, behavioural change and educating local people. [00:20:29] Interview ends.

Publication/Creation

23/02/2015

Physical description

207 MB 1 WAV file, 1 transcript

Notes

PDF transcript created by archivist for preservation and access reasons. See OH3/2/3 for original Microsoft Word format version of transcript.

Copyright note

Copyright in this interview is held by Wellcome Collection.

Permanent link